… The objective of this study was to compare the efficacy and toxicity of erlotinib, gefitinib, and
… and efficacy of erlotinib and gefitinib in patients with NSCLC. We concluded that gefitinib at …

… three available EGFR TKIs (gefitinib, erlotinib, and afatinib) for the … However, whether gefitinib,
erlotinib, or afatinib is most … to compare the effectiveness of gefitinib, erlotinib, and afatinib. …

… previous reports were female non-smokers, our results provide additional insights into the
efficacy of erlotinib following gefitinib failure. Based on our results, we believe there may be an …

… With regard to treatment efficacy for patients with EGFR-wt, … that gefitinib and erlotinib might
have almost equal efficacy for … erlotinib appears to have higher toxicity than gefitinib at each …

… efficacy difference between gefitinib and erlotinib as salvage therapy for advanced NSCLC.
The median TTF of around 3.4–5.5 months was compatible with results of clinical … the results …

… Our results show that afatinib was significantly associated with longer PFS compared with
gefitinib and erlotinib, even after adjustment for other potentially confounding prognostic factors…

… was to compare the efficacy of gefitinib and erlotinib in patients with … who began receiving
gefitinib or erlotinib treatment from … Clinical data, type of treatment response and survival time …

… The objective of this study was to compare the efficacy of gefitinib and erlotinib in … gefitinib
and erlotinib treatment. In this study, we retrospectively evaluated the difference in efficacy …

… No statistical differences in PFS were observed between gefitinib and erlotinib (2.0 months
vs. … Erlotinib and gefitinib had a similar efficacy in advanced squamous cell lung cancer. The …

… No solid evidence was found that afatinib had greater efficacy than gefitinib or erlotinib in
first-line treatment of EGFR-mutant NSCLC. However, afatinib was more effective than …